Stratec (ETR:SBS) Stock Price Down 2.5% – Here’s Why

Stratec SE (ETR:SBSGet Free Report)’s stock price dropped 2.5% during mid-day trading on Monday . The stock traded as low as €32.75 ($34.47) and last traded at €33.15 ($34.89). Approximately 7,178 shares changed hands during mid-day trading, an increase of 15% from the average daily volume of 6,253 shares. The stock had previously closed at €34.00 ($35.79).

Stratec Price Performance

The stock has a market cap of $398.26 million, a P/E ratio of 39.78, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16. The firm has a 50-day moving average price of €31.84 and a 200-day moving average price of €36.05. The company has a debt-to-equity ratio of 66.97, a quick ratio of 1.65 and a current ratio of 2.52.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Featured Stories

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.